Davis R M Inc. grew its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 4.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 292,264 shares of the company’s stock after purchasing an additional 13,019 shares during the quarter. Davis R M Inc.’s holdings in Procter & Gamble were worth $46,563,000 at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in the company. MOKAN Wealth Management Inc. boosted its position in shares of Procter & Gamble by 13.7% during the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after buying an additional 1,846 shares during the last quarter. Benjamin Edwards Inc. lifted its stake in Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after acquiring an additional 199,258 shares during the period. Caliber Wealth Management LLC KS lifted its stake in Procter & Gamble by 36.2% during the 2nd quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock valued at $2,836,000 after acquiring an additional 4,730 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $34,684,000. Finally, First Citizens Bank & Trust Co. raised its holdings in shares of Procter & Gamble by 12.8% during the second quarter. First Citizens Bank & Trust Co. now owns 156,874 shares of the company’s stock valued at $24,993,000 after purchasing an additional 17,836 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Stock Performance
NYSE:PG opened at $146.90 on Monday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The stock has a 50-day simple moving average of $152.93 and a two-hundred day simple moving average of $157.02. The firm has a market capitalization of $343.28 billion, a PE ratio of 21.45, a P/E/G ratio of 3.87 and a beta of 0.36. Procter & Gamble Company has a 52-week low of $144.46 and a 52-week high of $180.43.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio is presently 61.61%.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider directly owned 12,616 shares of the company’s stock, valued at $1,920,533.68. This trade represents a 3.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon R. Moeller sold 11,684 shares of the company’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the transaction, the chief executive officer directly owned 319,932 shares of the company’s stock, valued at approximately $48,703,248.36. This trade represents a 3.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 150,488 shares of company stock valued at $23,529,718. Company insiders own 0.20% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on PG shares. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Raymond James Financial dropped their price target on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Wells Fargo & Company lowered their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a report on Thursday, September 25th. Finally, Morgan Stanley set a $175.00 price target on Procter & Gamble in a research note on Monday, October 27th. Twelve equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $171.53.
Read Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- 3 Dividend Kings To Consider
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Election Stocks: How Elections Affect the Stock Market
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
